Creative Planning’s Direxion Daily S&P Biotech Bull 3X ETF LABU Stock Holding History

Creative Planning’s Portfolio LABU Stock Details LABU Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-370	Closed	-$584K	–	2352
2021 Q1	$584K	Sell	370 -59	-14%	-$138K	﹤0.01%	1333
2020 Q4	$862K	Buy	429 +99	+30%	+$158K	﹤0.01%	1027
2020 Q3	$353K	Buy	+330	New	+$378K	﹤0.01%	1320
2017 Q1	–	Sell	-127	Closed	-$80K	–	4794
2016 Q4	$80K	Buy	127 +17	+15%	+$12.8K	﹤0.01%	2016
2016 Q3	$107K	Sell	110 -174	-61%	-$144K	﹤0.01%	1802
2016 Q2	$160K	Buy	284 +271	+2,085%	+$170K	﹤0.01%	1372
2016 Q1	$7K	Hold	13	–	–	﹤0.01%	3413
2015 Q4	$23K	Buy	+13	New	+$21.1K	﹤0.01%	2742

Other funds holding LABU

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Jane Street New York $777B AUM 61.18% 1-Year Est. Return

TRCT

Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return

Wolverine Trading Chicago, Illinois $139B AUM 31.83% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

FTUS

Flow Traders U.S. New York $3.16B AUM 19.52% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

UMC

United Maritime Capital New York $15.2M AUM 45.42% 1-Year Est. Return

XSC

X-Square Capital Guaynabo, Puerto Rico $297M AUM 32.87% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Creative Planning's LABU Position: Q2 2021 in Review

Creative Planning sold out of Direxion Daily S&P Biotech Bull 3X ETF (LABU) in Q2 2021, closing a stake of 370 shares — an estimated $584K sold.

Creative Planning first reported a position in LABU in Q4 2015 and held it in 8 quarters. The position peaked at $862K in Q4 2020. 24 funds tracked by Wall St. Rank hold LABU as of Q2 2021.

Creative Planning reported no remaining Direxion Daily S&P Biotech Bull 3X ETF position as of Q2 2021 after selling out during the quarter.
Creative Planning sold 370 Direxion Daily S&P Biotech Bull 3X ETF shares in Q2 2021, an estimated $584K.
Creative Planning first reported a position in Direxion Daily S&P Biotech Bull 3X ETF in Q4 2015 and held it in 8 quarters.
Creative Planning's Direxion Daily S&P Biotech Bull 3X ETF position peaked at $862K in Q4 2020.
24 funds tracked by Wall St. Rank held Direxion Daily S&P Biotech Bull 3X ETF as of Q2 2021.

Based on Creative Planning's 13F filing for Q2 2021, filed 4 Aug 2021.